Holdings of T. Rowe Price Health Sciences Portfolio
T. ROWE PRICE EQUITY SERIES, INC. · Original filing · Compare with another fund · Report an error
- Net assets
- 751.7M $ including 718.1M $ in equities, 95.5 %
- Positions
- 168 in 16 countries
- Bond lines
- 1 from 1 company
- Top ten
- 47.3 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | ABIVAX SA | 7,941 | 1.1M $ | 0.14 % |
| 102 | Apogee Therapeutics Inc | 7,943 | 1.1M $ | 0.14 % |
| 103 | Sonova Holding AG | 4,392 | 1M $ | 0.14 % |
| 104 | Veeva Systems Inc | 5,700 | 1M $ | 0.13 % |
| 105 | OCULAR THERAPEUTIX INC | 100,706 | 988.9K $ | 0.13 % |
| 106 | COGENT BIOSCIENCES INC | 25,135 | 972.7K $ | 0.13 % |
| 107 | Stoke Therapeutics Inc | 29,312 | 959.1K $ | 0.13 % |
| 108 | Shattuck Labs Inc | 136,959 | 950.5K $ | 0.13 % |
| 109 | Biohaven Ltd | 60,593 | 901.6K $ | 0.12 % |
| 110 | Arrowhead Pharmaceuticals Inc | 10,689 | 871.3K $ | 0.12 % |
| 111 | Immix Biopharma Inc | 82,613 | 851.7K $ | 0.11 % |
| 112 | Incyte Corp | 7,454 | 845K $ | 0.11 % |
| 113 | BELITE BIO INC | 5,400 | 831.5K $ | 0.11 % |
| 114 | Parabilis Medicines Inc | 30,358 | 830.9K $ | 0.11 % |
| 115 | IQVIA Holdings Inc | 4,253 | 821.8K $ | 0.11 % |
| 116 | AVALYN PHARMA INC | 24,376 | 802.5K $ | 0.11 % |
| 117 | Sionna Therapeutics Inc | 17,807 | 783.3K $ | 0.10 % |
| 118 | Cullinan Therapeutics Inc | 42,900 | 781.2K $ | 0.10 % |
| 119 | Quest Diagnostics Inc | 3,609 | 764.9K $ | 0.10 % |
| 120 | Denali Therapeutics Inc | 29,350 | 754.9K $ | 0.10 % |
| 121 | BioNTech SE | 7,900 | 735.1K $ | 0.10 % |
| 122 | Corvus Pharmaceuticals Inc | 48,764 | 728.5K $ | 0.10 % |
| 123 | Pharvaris NV | 20,584 | 711.8K $ | 0.09 % |
| 124 | TARSUS PHARMACEUTICALS INC | 11,077 | 697.2K $ | 0.09 % |
| 125 | Disc Medicine Inc | 9,023 | 659.9K $ | 0.09 % |
| 126 | AKTIS ONCOLOGY INC | 20,013 | 645K $ | 0.09 % |
| 127 | Tenax Therapeutics Inc | 43,036 | 626.2K $ | 0.08 % |
| 128 | TYRA BIOSCIENCES INC | 18,800 | 600.5K $ | 0.08 % |
| 129 | Atrium Therapeutics Inc | 41,700 | 560.9K $ | 0.07 % |
| 130 | AVALO THERAPEUTICS INC | 29,080 | 537.4K $ | 0.07 % |
| 131 | Nanobiotix SA | 14,325 | 527.5K $ | 0.07 % |
| 132 | Olema Pharmaceuticals Inc | 40,697 | 509.1K $ | 0.07 % |
| 133 | Allogene Therapeutics Inc | 243,268 | 506K $ | 0.07 % |
| 134 | WAVE LIFE SCIENCES LTD | 84,993 | 493.8K $ | 0.07 % |
| 135 | Kyverna Therapeutics Inc | 55,173 | 491.6K $ | 0.07 % |
| 136 | HEMAB THERAPEUTICS HOLDINGS INC | 12,739 | 467.9K $ | 0.06 % |
| 137 | Alto Neuroscience Inc | 16,400 | 432.8K $ | 0.06 % |
| 138 | Procept Biorobotics Corp | 17,941 | 405.1K $ | 0.05 % |
| 139 | Seaport Therapeutics Inc | 18,421 | 400.1K $ | 0.05 % |
| 140 | Adaptive Biotechnologies Corp | 18,442 | 395.6K $ | 0.05 % |
| 141 | SpyGlass Pharma Inc | 17,450 | 388.4K $ | 0.05 % |
| 142 | Iovance Biotherapeutics Inc | 92,649 | 385.4K $ | 0.05 % |
| 143 | Celcuity Inc | 3,682 | 385.2K $ | 0.05 % |
| 144 | Xencor Inc | 22,853 | 367.9K $ | 0.05 % |
| 145 | CABALETTA BIO INC | 110,667 | 344.2K $ | 0.05 % |
| 146 | Generate Biomedicines Inc | 19,115 | 322.5K $ | 0.04 % |
| 147 | Inspire Medical Systems Inc | 7,200 | 321.2K $ | 0.04 % |
| 148 | Evommune Inc | 23,915 | 317.8K $ | 0.04 % |
| 149 | CRESCENT BIOPHARMA INC | 17,631 | 317.4K $ | 0.04 % |
| 150 | Eikon Therapeutics Inc | 20,976 | 273.7K $ | 0.04 % |
| 151 | BICYCLE THERAPEUTICS PLC | 62,846 | 266.5K $ | 0.04 % |
| 152 | SENSORION SA | 854,563 | 230.9K $ | 0.03 % |
| 153 | Xenon Pharmaceuticals Inc | 3,500 | 211.3K $ | 0.03 % |
| 154 | Odyssey Therapeutics Inc | 11,276 | 211K $ | 0.03 % |
| 155 | Agios Pharmaceuticals Inc | 5,657 | 209.9K $ | 0.03 % |
| 156 | IMMATICS NV | 20,700 | 209.7K $ | 0.03 % |
| 157 | BioMarin Pharmaceutical Inc | 3,600 | 206K $ | 0.03 % |
| 158 | GE HealthCare Technologies Inc | 2,800 | 179.2K $ | 0.02 % |
| 159 | Immuneering Corp | 35,835 | 178.8K $ | 0.02 % |
| 160 | DYNE THERAPEUTICS INC | 7,100 | 157.7K $ | 0.02 % |
| 161 | CARIS LIFE SCIENCES INC | 8,815 | 157.1K $ | 0.02 % |
| 162 | Entrada Therapeutics Inc | 20,159 | 148.4K $ | 0.02 % |
| 163 | BridgeBio Oncology Therapeutics Inc | 15,774 | 120.2K $ | 0.02 % |
| 164 | REVOLUTION MEDICINES INC WTS 12/26 | 11,096 | 104.3K $ | 0.01 % |
| 165 | MAPLIGHT THERAPEUTICS INC | 2,576 | 92.3K $ | 0.01 % |
| 166 | Tectonic Therapeutic Inc | 2,081 | 71.5K $ | 0.01 % |
| 167 | Aura Biosciences Inc | 9,908 | 70.3K $ | 0.01 % |
| 168 | GENEDX HOLDINGS CORP WTS 7/26 | 11,396 | 33.1 $ |
The bonds it holds
This fund holds one bond line from 1 company. Only companies that already have a page on Titelia appear here.
| Rank | Company | Bond lines | Value | Weight |
|---|---|---|---|---|
| 1 | Immunocore Holdings PLC | 1 | 670.2K $ | 0.09 % |
Sector breakdown
- Health care 71.5 %
- Technology 0.1 %
- Unattributed 28.4 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 98.8 %
- JPY 0.5 %
- HKD 0.4 %
- CHF 0.1 %
- EUR 0.1 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 94.4 %
- Netherlands 1.0 %
- Bermuda 0.8 %
- Denmark 0.7 %
- United Kingdom 0.5 %
- Japan 0.5 %
- Ireland 0.4 %
- Hong Kong SAR China 0.4 %
- Cayman Islands 0.3 %
- France 0.3 %
- Israel 0.2 %
- Switzerland 0.1 %
- Other countries 0.3 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 144 | 678M $ | 94.41 % |
| 2 | Netherlands | 4 | 7.4M $ | 1.02 % |
| 3 | Bermuda | 1 | 5.6M $ | 0.77 % |
| 4 | Denmark | 2 | 5.1M $ | 0.72 % |
| 5 | United Kingdom | 2 | 3.9M $ | 0.54 % |
| 6 | Japan | 1 | 3.6M $ | 0.51 % |
| 7 | Ireland | 2 | 3M $ | 0.41 % |
| 8 | Hong Kong SAR China | 1 | 2.8M $ | 0.40 % |
| 9 | Cayman Islands | 2 | 1.9M $ | 0.27 % |
| 10 | France | 3 | 1.8M $ | 0.25 % |
| 11 | Israel | 1 | 1.7M $ | 0.23 % |
| 12 | Switzerland | 1 | 1M $ | 0.15 % |
Cite this page
Titelia. "Holdings of T. Rowe Price Health Sciences Portfolio". https://titelia.com/en/funds/S000002083